Anne M. Lachiewicz

Infectious Disease
101 Manning Dr
Chapel Hill, NC 27514

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.

Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.

Journal: Antimicrobial agents and chemotherapy
Published: April 30, 2026

Utilization of a CMV T Cell Immunity Assay to Guide Secondary Prophylaxis in Solid Organ Transplant Recipients.

Utilization of a CMV T Cell Immunity Assay to Guide Secondary Prophylaxis in Solid Organ Transplant Recipients.

Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: September 29, 2025

A Comparison of Piperacillin-Tazobactam With Conventional Antibiotics for Prophylaxis in Lower Extremity Type III Open Fractures.

A Comparison of Piperacillin-Tazobactam With Conventional Antibiotics for Prophylaxis in Lower Extremity Type III Open Fractures.

Journal: Cureus
Published: August 24, 2025

Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis.

Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis.

Journal: CHEST critical care
Published: November 29, 2024

Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).

Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 06, 2023

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

Journal: JAMA
Published: July 10, 2023

Utility of Urine Cultures During Febrile Neutropenia Workup in Hematopoietic Stem Cell Transplantation Recipients Without Urinary Symptoms.

Utility of Urine Cultures During Febrile Neutropenia Workup in Hematopoietic Stem Cell Transplantation Recipients Without Urinary Symptoms.

Journal: Open forum infectious diseases
Published: January 31, 2023

Microbiological cultures and antimicrobial prophylaxis in patients undergoing total pancreatectomy with islet cell autotransplantation.

Microbiological cultures and antimicrobial prophylaxis in patients undergoing total pancreatectomy with islet cell autotransplantation.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: October 17, 2022

Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.

Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.

Journal: medRxiv : the preprint server for health sciences
Published: October 07, 2022

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.

Journal: medRxiv : the preprint server for health sciences
Published: September 29, 2022

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.

Journal: mBio
Published: September 22, 2022

Liver transplantation from a SARS-COV-2-positive donor: A road ahead or not.

Liver transplantation from a SARS-COV-2-positive donor: A road ahead or not.

Journal: Journal of liver transplantation
Published: September 19, 2022
Showing 1-12 of 43

Last Updated: 09/26/2026